Erratum: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease (PLoS ONE (2020) 15:11 (e0240855) DOI: 10.1371/journal.pone.0240855)

Soudabeh Fazeli; Majid Motovali-Bashi; Maryam Peymani; Motahare Sadat Hashemi; Masoud Etemadifar; Mohammad Hossein Nasr-Esfahani; Kamran Ghaedi

ArticleOPEN ACCESS

Erratum: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease (PLoS ONE (2020) 15:11 (e0240855) DOI: 10.1371/journal.pone.0240855)

PLoS ONE

DOI: 10.1371/journal.pone.0244776

5Citations

3Readers

Abstract

There is an error in affiliation 2 for author Maryam Peymani. The correct affiliation 2 is: Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

Cite

CITATION STYLE

APA

Fazeli, S., Motovali-Bashi, M., Peymani, M., Hashemi, M. S., Etemadifar, M., Nasr-Esfahani, M. H., & Ghaedi, K. (2020, December 1). Erratum: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease (PLoS ONE (2020) 15:11 (e0240855) DOI: 10.1371/journal.pone.0240855). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0244776

Erratum: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease (PLoS ONE (2020) 15:11 (e0240855) DOI: 10.1371/journal.pone.0240855)

Abstract

Cite

Register to see more suggestions